ICN Recognised as Clinical Research Company of the Year at the …
The News Review:
- ICN Recognised as Clinical Research Company of the Year at the …
- Multiple Myeloma Research Consortium And Merck Initiate Phase II …
- Nemours lands grant to study diabetes
- Review of Takeda’s Febuxostat New Drug Application Continues Past …
- Research Finds Healthy Use For Tanning Beds As Pain Treatment
ICN Recognised as Clinical Research Company of the Year at the …
PR Newswire UK (press release) UK
This accoladewas based on the combined success of ICN teams and individuals who wonmultiple awards and was presented by Professor Sir Trevor Jones. ICNClinical Research won gold silver and bronze in both the Clinical ResearchTeam of the Year and Clinical Research Associate of the Year categories. Inaddition to this recognition ICN also received a bronze award in theProject Management category. The PharmaTimes awards which were announced at a ceremony in London onThursday 15th January recognise and reward excellence in pharmaceuticalclinical development. In total ICN had over thirty staff short-listed asfinalists across different categories the highest number from anyorganisation. Alan Morgan Chief perating fficer ICN Clinical Research commented:”We are delighted with our success at the PharmaTimes awards as itrecognises the outstanding contribution that our people have made to theoverall success of the organisation.
Multiple Myeloma Research Consortium And Merck Initiate Phase II …
Medical News Today (press release) UK
At the core of the MMRC model is an Executive Committee based in Norwalk Conn. which provides strategic scientific and clinical oversight of the MMRC’s drug development projects. The MMRC’s Member Institutions include prominent multiple myeloma clinical research centers in North America: City of Hope Dana-Farber Cancer Institute Emory University’s Winship Cancer Institute the Cancer Center at Hackensack University Medical Center H. Lee Moffitt Cancer Center & Research Institute Indiana University Mayo Clinic hio State University St. Vincent’s Comprehensive Cancer Center of Saint Vincent Catholic Medical Centers of New York University Health Network (Princess Margaret Hospital) University of Chicago University of Michigan University of California – San Francisco and Washington University. The MMRC’s collaborative model also includes a Tissue and Data Bank which serve as a “bridge” between laboratory and clinical research conducted by the MMRC members and a vital resource in advancing MMRC clinical trials and correlative science studies. As a results-driven organization the MMRC has to date partnered with pharmaceutical and academic sponsors to facilitate 17 Phase I and II clinical trials of the most promising novel investigational compounds and new potential combination treatment approaches for myeloma.
Nemours lands grant to study diabetes
Bizjournals.com NC
He will coordinate with fellow Nemours doctors and co-investigators Jorge Daaboul in rlando Mark Kummer in Pensacola and Grafton Reeves in Wilmington Del. “Recent research has shown that compared with adults adolescents may derive less benefit from using continuous glucose sensors” Wysocki said adding that it may be because they don’t use the device as consistently as adults or don’t use the information to adjust eating insulin intake and exercise. Nemours is a leader in clinical research on continuous glucose sensors in treating Type 1 diabetes in children and adolescents. The grant project will allow its researchers to enroll 150 adolescents and their parents in the five-year study.
Review of Takeda’s Febuxostat New Drug Application Continues Past …
PR Newswire (press release) NY
Food and Drug Administration (FDA) that FDA will not be able to complete its review of the febuxostat New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of January 18 2009. “The FDA raised no issues with the NDA submission or the data included in it rather FDA stated that due to its inability to complete routine inspections at investigator sites and at a Clinical Research rganization vendor involved in the development of febuxostat the PDUFA date for febuxostat would be missed by the FDA” said Dean Sundberg senior vice president regulatory affairs at Takeda Global Research & Development Center Inc. “Takeda has taken all necessary steps and provided all necessary information at this point in the NDA review process and we await FDA’s completion of these routine inspections and look forward to receiving a final approval date for febuxostat. Febuxostat is currently under review with FDA for once-daily oral treatment of hyperuricemia in patients with gout. The NDA for febuxostat included data from multiple clinical trials involving more than 4000 patients. In November 2008 FDA’s Arthritis Advisory Committee recommended febuxostat for approval by a vote of 12-0 with one panel member abstaining.
Research Finds Healthy Use For Tanning Beds As Pain Treatment
WFMY News 2 NC
a rheumatologist at Wake Forest Baptist and a researcher on the study. “The evaluation of alternative therapies for patients with fibromyalgia syndrome based on our increased understanding of how pain signals are generated and sustained is an important pursuit at many clinical research centers. ” Traditional treatments for fibromyalgia are medications such as antidepressants analgesics and non-steroidal anti-inflammatory drugs and non-pharmacologic approaches most importantly regular participation in an exercise program. In a previous tanning addiction study participants getting UV light treatments reported improvement in their arthritis and back pain Feldman said. That earlier study found that frequent tanning bed users may get more out of the experience than darker skin – exposure to ultraviolet light may produce a “relaxing” effect that lures tanners back to the beds. According to Feldman this cannot be just a direct effect of warmth causing an increase in blood flow and a decrease in muscle spasm and tension because there was greater relaxation with UV compared to the non-UV bed users.
Related from Alternativemonster: Physical therapy effective in treating back and neck pain
Written by admin on January 19th, 2009 with
no comments.
Read more articles on News.